Abstract
Cardiovascular complications of anticancer chemotherapy are emerging as a major issue in public health, considering the increase in the cancer survival rate during last years. Cardiotoxicity caused by chemotherapeutics as doxorubicin (doxo), is a serious condition, that can evolve to chronic cardiomyopathy, congestive heart failure and patient death. Studies focused on the signaling activ…